CYTX vs. ICU, LUCD, CODX, CTCX, DRIO, MDAI, LNSR, CTSO, MODD, and DXR
Should you be buying Cytori Therapeutics stock or one of its competitors? The main competitors of Cytori Therapeutics include SeaStar Medical (ICU), Lucid Diagnostics (LUCD), Co-Diagnostics (CODX), Carmell (CTCX), DarioHealth (DRIO), Spectral AI (MDAI), LENSAR (LNSR), Cytosorbents (CTSO), Modular Medical (MODD), and Daxor (DXR). These companies are all part of the "medical" sector.
SeaStar Medical (NASDAQ:ICU) and Cytori Therapeutics (NASDAQ:CYTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, community ranking, dividends, analyst recommendations, profitability and media sentiment.
Cytori Therapeutics received 441 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 73.67% of users gave Cytori Therapeutics an outperform vote.
Cytori Therapeutics has higher revenue and earnings than SeaStar Medical.
SeaStar Medical has a beta of -1.18, indicating that its stock price is 218% less volatile than the S&P 500. Comparatively, Cytori Therapeutics has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500.
In the previous week, SeaStar Medical had 2 more articles in the media than Cytori Therapeutics. MarketBeat recorded 2 mentions for SeaStar Medical and 0 mentions for Cytori Therapeutics. Cytori Therapeutics' average media sentiment score of 0.36 beat SeaStar Medical's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the media.
1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 2.6% of Cytori Therapeutics shares are owned by institutional investors. 4.5% of SeaStar Medical shares are owned by insiders. Comparatively, 0.7% of Cytori Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
SeaStar Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -242.60%. Cytori Therapeutics' return on equity of 0.00% beat SeaStar Medical's return on equity.
Summary
SeaStar Medical and Cytori Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.
Get Cytori Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CYTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CYTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cytori Therapeutics Competitors List
Related Companies and Tools
